Jump to main content
Jump to site search

Issue 9, 2018
Previous Article Next Article

Cycloplatinated(II) complexes bearing an O,S-heterocyclic ligand: search for anticancer drugs

Author affiliations

Abstract

2-Mercaptopyridine N-oxide sodium salt (NaSpyO) was used as a bioactive ligand for the preparation of two new cycloplatinated(II) complexes. The reaction of the NaSpyO ligand with the cyclometalated platinum complexes [PtCl(C^N)(dmso)], 1, C^N = deprotonated form of 2-phenylpyridine (ppy, 1a) or 7,8-benzoquinoline (bzq, 1b), afforded the complexes [Pt(C^N)(SpyO)], 2, C^N = ppy (2a) or bzq (2b). These complexes were characterized in solution via NMR spectroscopy. Single-crystal X-ray determination (in the case of 2a) and theoretical calculations confirmed that the SpyO ligand acted as a chelate (sulfur atom is cis to the carbon atom of the C^N ligand). The optical properties of both complexes were studied by UV-visible spectroscopy. The lower energy bands in 2 had a mixed transition character (1MLCT/1LC/1L′LCT, L = C^N and L′ = SpyO), and this assignment was supported by the time-dependent density functional theory (TD-DFT) calculations. The cytotoxic activities of 2 were tested on five different human cancer cell lines: A549 (non-small cell lung cancer), MCF-7 (breast cancer), SKOV3 (ovarian cancer), MDA-MB-231 (breast cancer), and HT-29 (colon colorectal cancer). The effects of these compounds on the proliferation of the non-tumoral breast cell line (MCF-12A) showed good selectivity among the tumorigenic and non-tumorigenic cell lines. These complexes revealed good to moderate anti-proliferative activity. Electrophoresis mobility shift assays and molecular docking studies were also carried out on 2 to determine the specific binding mode and the orientation of binding to DNA.

Graphical abstract: Cycloplatinated(ii) complexes bearing an O,S-heterocyclic ligand: search for anticancer drugs

Back to tab navigation

Supplementary files

Publication details

The article was received on 18 Mar 2018, accepted on 27 Mar 2018 and first published on 29 Mar 2018


Article type: Paper
DOI: 10.1039/C8NJ01332B
Citation: New J. Chem., 2018,42, 7177-7187
  •   Request permissions

    Cycloplatinated(II) complexes bearing an O,S-heterocyclic ligand: search for anticancer drugs

    M. Fereidoonnezhad, Z. Ramezani, M. Nikravesh, J. Zangeneh, M. Golbon Haghighi, Z. Faghih, B. Notash and H. R. Shahsavari, New J. Chem., 2018, 42, 7177
    DOI: 10.1039/C8NJ01332B

Search articles by author

Spotlight

Advertisements